Literature DB >> 2379162

Paracrine growth stimulation of androgen-responsive Shionogi Carcinoma 115 by its autonomous subline (Chiba Subline 2).

Y Furuya1, N Sato, K Akakura, T Ichikawa, N Suzuki, R Sato, J Shimazaki.   

Abstract

Shionogi Carcinoma 115 cells (SC 115 cells) and Chiba Subline 2 cells (CS 2 cells) are clones of an androgen-responsive mouse tumor cell line and its autonomous subline, respectively. Since it was reported that the growth of cells from SC 115 was regulated by an androgen-induced fibroblast growth factor (FGF)-like peptide (1), the present study was aimed at examining whether a similar growth factor was secreted by CS 2 cells in the absence of testosterone. Although SC 115 cells did not grow in the serum-free medium without androgens, SC 115 cells could proliferate in mixed culture with CS 2 cells, suggesting stimulation of SC 115 cells by CS 2 cells. It was shown that CS 2 cells secreted a growth factor without the influence of testosterone, and this factor promoted the growth of SC 115 and CS 2 cells, as well as that of BALB/3T3 cells. The factor was partially purified from serum-free conditioned medium obtained from cultures of CS 2 cells. It showed an affinity for heparin, stability to heat and acid treatments, a decrease in activity when anti-basic FGF antibody was added to cultures, and an estimated molecular weight of approximately 50,000. Therefore, the factor seemed to have the nature of an FGF-like peptide. It was concluded that, in the absence of testosterone, CS 2 cells produced an FGF-like growth factor which controlled the growth of both CS 2 cells and parent SC 115 cells, in autocrine and paracrine manners, respectively.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2379162

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  5 in total

Review 1.  Intermittent androgen deprivation.

Authors:  N A Dawson
Journal:  Curr Oncol Rep       Date:  2000-09       Impact factor: 5.075

2.  Three cell lines showing androgen-dependent, -independent, and -suppressed phenotypes, established from a single tumor of androgen-dependent Shionogi carcinoma 115.

Authors:  T Yamaguchi; K Kawamoto; N Uchida; K Uchida; S Watanabe
Journal:  In Vitro Cell Dev Biol       Date:  1992-04

3.  Induction of programmed death/apoptosis androgen-dependent mouse mammary tumor cell line (Shionogi Carcinoma 115) by androgen withdrawal.

Authors:  Y Furuya; J T Isaacs; J Shimazaki
Journal:  Jpn J Cancer Res       Date:  1995-12

4.  Appearance of malignant phenotype with partial loss of hormone dependency in androgen-dependent Shionogi Carcinoma 115 transfected with hst-1 gene.

Authors:  Y Furuya; N Sato; Y Watabe; J Shimazaki
Journal:  Jpn J Cancer Res       Date:  1991-11

5.  Progression of androgen-sensitive mouse tumor (Shionogi carcinoma 115) to androgen-insensitive tumor after long-term removal of testosterone.

Authors:  N Sato; Y Watabe; H Suzuki; J Shimazaki
Journal:  Jpn J Cancer Res       Date:  1993-12
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.